Canada
The company reported steady growth over the latest fiscal period, but scaled back annual projections due to coronavirus concerns
Hi, what are you looking for?
Mugglehead Investment Magazine
The weed wire
COVID-19 has cooled the overall demand for extraction services, but executives hold out hope for the rest of 2020
Cannabis
The company said lower general sales volumes were offset by higher medical and international sales
The weed wire
Company board approves 1-for-12 share consolidation plan in attempt to remain listed on NYSE
The weed wire
The psychedelic medicine company has surged since going public last month and is quickly expanding its research footprint
The weed wire
The non-psychoactive formulation completed its preclinical trial Monday
COVID-19
The company said it's upped wages for existing employees and started a lunch program to support local restaurants
The weed wire
A new Journal of the American Medical Association study shows a five-fold jump in EVALI cases in states that prohibit weed
Canada
As prisons around the world depopulate, Canada should consider expunging cannabis offences says NORML Canada executive director Caryma Sa'd
COVID-19
Cannabis sales are on pace for US$745 million in 2020, which could be a catalyst for legalization in neighbouring states, says BDS Analytics